7th Mar 2005 17:38
GlaxoSmithKline PLC07 March 2005 Director's Interests I give below details of changes in directors' interests in the Ordinary Sharesof GlaxoSmithKline plc. 03 March 2005 The Administrators of the SmithKline Beecham Employee Benefit Trust ("The Trust") notified the Company on 07 March 2005 that 231 Ordinary shares in the Company had been sold on behalf of a participant in the GlaxoSmithKline Annual Investment Plan at a price of £13.152 per share. The Trust also notified the Company on 07 March 2005 that 798 Ordinary shares had been transferred from the Trust to a participant in the GlaxoSmithKline Annual Investment Plan. The Trust is a discretionary fund of which all non US employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. One of the Company's directors, John Coombe is thereforeinterested in the shares held in the fund from time to time in the same way asother non US employees or former employees of GlaxoSmithKline plc and itssubsidiaries. S M Bicknell Company Secretary 07 March 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline